Nasri Hamid, Ahmadi Ali, Rafieian-Kopaei Mahmood, Bashardoust Bahman, Nasri Parto, Mubarak Muhammed
Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Epidemiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Nephropathol. 2015 Jan;4(1):19-23. doi: 10.12860/jnp.2015.04. Epub 2015 Jan 1.
IgA nephropathy (IgAN) is the most prevalent primary chronic glomerulopathy worldwide. Thus, it is of vital importance to search for factors aggravating the disease progress, monitor disease activity and predict disease-specific therapy. C4d is a well-known biomarker of the complement cascade with a potential to meet the above needs.
The aim of our study was, therefore, to determine whether C4d staining at the time of kidney biopsy had any correlation with the demographic, clinical and biochemical variables in IgAN.
The definition of IgAN requires the presence of diffuse and global IgA deposits which were graded ≥2+ and weak C1q deposition. C4d immunohistochemical staining was conducted retrospectively on 29 renal biopsies of patients with IgAN, which were selected randomly from all biopsies. C4d immunohistochemical staining was performed on 3-μm deparaffinized and rehydrated sections of formaldehyde-fixed, paraffin-embedded renal tissues.
Of 29 selected patients, 68% were male. In this study, 54.2±25 percent of glomeruli in all biopsies were positive for C4d. The mean and standard deviation (SD) of serum creatinine and the magnitude of proteinuria were 1.72±1.2 mg/dl and 1582±1214 mg/day, respectively. In this study, we observed statistically significant correlations of percent C4d positivity with the serum creatinine (r=0.61, p=0.0005), magnitude of proteinuria (r=0.72, p=0.0001), the proportion of globally sclerotic glomeruli (r=0.43, p=0.02) and the proportion of tubulointerstitial fibrosis (r=0.54, p=0.0023).
The results from our investigation on C4d positivity in biopsy-proven cases of IgAN are in accord with some of the previous studies. These findings, however, require further validation in larger samples.
IgA肾病(IgAN)是全球最常见的原发性慢性肾小球病。因此,寻找加重疾病进展的因素、监测疾病活动及预测疾病特异性治疗至关重要。C4d是补体级联反应中一种知名的生物标志物,有潜力满足上述需求。
因此,我们研究的目的是确定肾活检时C4d染色是否与IgAN患者的人口统计学、临床和生化变量存在任何相关性。
IgAN的定义要求存在弥漫性和全球性IgA沉积,分级≥2+且C1q沉积较弱。对29例IgAN患者的肾活检组织进行回顾性C4d免疫组化染色,这些活检组织是从所有活检组织中随机选取的。在甲醛固定、石蜡包埋的肾组织经脱蜡和水化处理后的3μm切片上进行C4d免疫组化染色。
在29例入选患者中,68%为男性。在本研究中,所有活检组织中54.2±25%的肾小球C4d呈阳性。血清肌酐的平均值和标准差(SD)以及蛋白尿程度分别为1.72±1.2mg/dl和1582±1214mg/天。在本研究中,我们观察到C4d阳性百分比与血清肌酐(r=0.61,p=0.0005)、蛋白尿程度(r=0.72,p=0.0001)、全球硬化性肾小球比例(r=0.43,p=0.02)和肾小管间质纤维化比例(r=0.54,p=0.0023)之间存在统计学显著相关性。
我们对经活检证实的IgAN病例中C4d阳性的研究结果与之前的一些研究一致。然而,这些发现需要在更大样本中进一步验证。